Add-on Acquisition • Medical Products

Catheter Precision Acquires Catheter Precision

On September 12, 2022, Catheter Precision acquired medical products company Catheter Precision

Acquisition Context
  • This is Catheter Precision’s 1st transaction in the Medical Products sector.
  • This is Catheter Precision’s 1st transaction in the United States.
  • This is Catheter Precision’s 1st transaction in New Jersey.

Explore All 2731 Add-on Acquisition Medical Products Deals - Search the Database Free


M&A Deal Summary

Date September 12, 2022
Target Catheter Precision
Sector Medical Products
Buyer(s) Catheter Precision
Deal Type Add-on Acquisition

Target Company

Catheter Precision

Mt. Olive, New Jersey, United States
Catheter Precision is a medical device company focused on cardiac electrophysiology. Catheter Precision has developed two cost-effective, user-friendly, and advanced technologies to improve the treatment of cardiac arrhythmias. Catheter Precision was founded in 2016 and is based in Mt. Olive, New Jersey.
Explore More Deals

Browse All 215,130 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Catheter Precision

Fort Mill, South Carolina, United States

Category Company
Founded 2002
Sector Medical Products
Employees22
Revenue 4M USD (2020)
DESCRIPTION

Catheter Precision design, develop, and commercialize excimer lasers as tools for the treatment of vascular and dermatological diseases. Catheter Precision was incorporated in 2002 and is headquartered in Fort Mill, South Carolina.


Deal Context for Buyer #
Overall 1 of 2
Sector: Medical Products 1 of 2
Type: Add-on Acquisition 1 of 2
State: New Jersey 1 of 1
Country: United States 1 of 2
Year: 2022 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-08-16 Ra Medical - Pharos Dermatology Business

Carlsbad, California, United States

Ra Medical’s Pharos Dermatology Business is FDA-cleared and used as a tool in the treatment of chronic skin diseases, including psoriasis, vitiligo, atopic dermatitis, and leukoderma.

Sell $4M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2025-01-15 PeriKard

United States

PeriKard is a development stage company developing a kit of tools to enable physicians to more easily gain access to the pericardial space of the heart.

Buy -